Courcoulas, A
Abu Dayyeh, B K
Eaton, L
Robinson, J
Woodman, G
Fusco, M
Shayani, V
Billy, H
Pambianco, D
Gostout, C
Article History
Received: 9 June 2016
Revised: 31 August 2016
Accepted: 20 October 2016
First Online: 23 December 2016
Competing interests
: AC has received research grants from the NIH-NIDDK, Nutrisystem, Ethicon J & J Healthcare, Covidien, is a consultant for Apollo Endosurgery for this project and was a project consultant for Ethicon J & J Healthcare. BAD is a consultant for Apollo Endosurgery and Xlumina. He has research agreements with Aspire Bariatrics and GI Dynamics. LE was a consultant to Allergan Medical while the study was being conducted. She currently serves as a consultant to Apollo Endosurgery and is the principal consultant for UltaMed Corporation. JR was an employee of Allergan Medical during the close of the study but did not work on the trial, and currently serves as a consultant to Apollo Endosurgery. He currently is an employee of Simulstat. GW is a clinical trial investigator with USGI, ReShape and Obalon. MF is a former Allergan consultant and proctor. VS is a consultant for Apollo Endosurgery. He has research agreements with Apollo Endosurgery and Obalon as well as a clinical trial investigator for Obalon. HB is a consultant for Transenterix and speaker for Ethicon and Apollo Endosurgery. DP has nothing to disclose. CG is a consultant for Apollo Endosurgery and Olympus Corporation. He has performed sponsored research for Olympus Corporation and GI Supply. AC and JR had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.